China's Tigermed receives Hong Kong exchange nod for listing in 2020

Chinese clinical research service provider Hangzhou Tigermed Consulting Co. has won approval from the Hong Kong stock exchange for its second listing, which could raise about $1 billion in what would be Asia’s largest health-care listing this year, according to people familiar with the matter.